Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Vaccines specialty page provides vaccine-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Supplemental Biologics License Application for .5 mL Influenza Vaccine in Children 6-35 Months Accepted by FDA
If this indication is approved, physicians will be able to reserve the vaccine for young children to protect them against the 2019-2020 flu season.
Vaccination Week in the Americas Set to Immunize 70 Million Individuals
Following outbreaks of measles and yellow fever in parts of Central America, South America, and the Caribbean, PAHO is leading the 16th annual Vaccination Week in the Americas in an effort to vaccinate 70 million individuals against several diseases.
FDA Grants Breakthrough Therapy Designation for Pfizer's MenB Vaccine in Children
This is the first Breakthrough Therapy designation for a MenB vaccine to help protect children as young as 1 year of age.

Top Infectious Disease News of the Week—April 8, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Recent Spike in US Mumps Cases Linked to Vaccine's Waning Protection
New strains of the mumps virus are not to blame for the recent resurgence of cases, say researchers in a new study, instead pinning the recent outbreaks on declining protective effects of the mumps vaccine over time.
Novavax Presents Data on Trials for Improved Flu Vaccine and Candidate for First RSV Vaccine
Representatives from Novavax, Inc., an American-based biotechnology company, presented data at the recent World Vaccine Congress in Washington, DC, on their vaccines under development for the flu and RSV.
Top Infectious Disease News of the Week—April 1, 2018
In case you missed them, we've compiled the top five infectious disease articles from this past week.
Study Finds Pertussis Vaccines
Investigators set out to find out why pertussis rates in the United States have been rising steadily despite the availability of a vaccine.